BIOMARIN PHARMACEUTICAL INC.

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange BIOMARIN PHARMACEUTICAL INC. stocks are traded under the ticker BM8.

BIOMARIN PHARMACEUTICAL INC. is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for BIOMARIN PHARMACEUTICAL INC. has a max estimate of 131.60 EUR and a min estimate of 75.20 EUR.

BM8 earnings for the last quarter are 0.20 EUR whereas the estimation was 0.21 EUR which accounts for −5.20% surprise. Estimated earnings for the next quarter are 0.18 EUR. See more details about BIOMARIN PHARMACEUTICAL INC. earnings.

BIOMARIN PHARMACEUTICAL INC. revenue for the last quarter amounts to ‪549.93 M‬ EUR despite the estimated figure of ‪571.23 M‬ EUR. In the next quarter revenue is expected to reach ‪578.78 M‬ EUR.

Yes, you can track BIOMARIN PHARMACEUTICAL INC. financials in yearly and quarterly reports right on TradingView.

No, BM8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, BM8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL INC. stock right from TradingView charts — choose your broker and connect to your account.

BM8 reached its all-time high on Jul 21, 2015 with the price of 139.50 EUR, and its all-time low was 2.85 EUR and was reached on Nov 9, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL INC. on this list?

We've gathered analysts' opinions on BIOMARIN PHARMACEUTICAL INC. future price: according to them, BM8 price has a max estimate of 131.60 EUR and a min estimate of 75.20 EUR. Read a more detailed BIOMARIN PHARMACEUTICAL INC. forecast: see what analysts think of BIOMARIN PHARMACEUTICAL INC. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL INC. EBITDA is ‪270.10 M‬ EUR, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL INC. financial statements.